LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 2543 | 1058 | 5418 | 0.1952 | -0.5529 |
MDA-MB-231 | Luminespib | 10 | uM | LJP5 | 72 | hr | 1311 | 992 | 5079 | 0.1953 | -0.1334 |
MDA-MB-231 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 993 | 5079 | 0.1956 | -0.1327 |
MCF 10A | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2174 | 11103 | 0.1959 | 0.0961 |
BT-20 | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 769 | 3925 | 0.1959 | -0.2984 |
BT-20 | Withaferin A | 10 | uM | LJP6 | 72 | hr | 1334 | 771 | 3925 | 0.1963 | -0.2993 |
MCF7 | QL-XII-47 | 10 | uM | LJP6 | 72 | hr | 1389 | 1074 | 5445 | 0.1966 | -0.1261 |
MCF7 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1389 | 1167 | 5905 | 0.1974 | -0.0811 |
BT-20 | Geldanamycin | 10 | uM | LJP5 | 72 | hr | 1334 | 796 | 4033 | 0.1974 | -0.2775 |
MCF7 | Buparlisib | 1.11 | uM | LJP5 | 72 | hr | 1389 | 1167 | 5905 | 0.1975 | -0.0810 |
MCF 10A | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 2195 | 11103 | 0.1977 | 0.1000 |
MCF7 | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1389 | 1168 | 5905 | 0.1977 | -0.0803 |
SK-BR-3 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 2543 | 1140 | 5752 | 0.1982 | -0.4943 |
MCF 10A | PI103 | 10 | uM | LJP6 | 72 | hr | 1694 | 2227 | 11217 | 0.1985 | 0.1048 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1081 | 5445 | 0.1986 | -0.1204 |
MDA-MB-231 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1009 | 5079 | 0.1987 | -0.1258 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2228 | 11217 | 0.1987 | 0.1055 |
BT-20 | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 801 | 4033 | 0.1989 | -0.2736 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 2233 | 11217 | 0.1990 | 0.1064 |
SK-BR-3 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 2543 | 1077 | 5418 | 0.1991 | -0.5453 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 782 | 3925 | 0.1992 | -0.2908 |
SK-BR-3 | PF562271 | 10 | uM | LJP6 | 72 | hr | 2543 | 1079 | 5418 | 0.1994 | -0.5446 |
Hs 578T | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 765 | 618 | 3101 | 0.1994 | -0.1008 |
BT-20 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1334 | 781 | 3925 | 0.1994 | -0.2940 |
SK-BR-3 | TWS119 | 10 | uM | LJP5 | 72 | hr | 2543 | 1147 | 5752 | 0.1994 | -0.4923 |